Guidance: Antimicrobial resistance: develop solutions in the UK

Imported from official source

Overview of the UK's antimicrobial resistance (AMR) research infrastructure and advantages of investment in the UK's life science sector to support new treatments.

A summary of the UK’s strengths as centre for AMR, including:

  • reasons to select the UK as a partner for development
  • information on infrastructure for treatment, diagnostics and systems research and development
  • This is an extract. The publication continues at the source.

    Read the original at the source: https://www.gov.uk/government/publications/antimicrobial-resistance-develop-solutions-in-the-uk

    Officially imported this from Life Sciences Organisation’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    Life Sciences Organisation — imported from official source
    Official source
    https://www.gov.uk/government/organisations/life-sciences-organisation.atom ATOM
    Imported
    September 20, 2026 19:53
    Versions
    1 recorded
    Identity
    https://www.gov.uk/government/publications/antimicrobial-resistance-develop-solutions-i...

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.